You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020137022
Dec 20205407
Jan 20211804
Feb 20212406
Mar 202168014
Apr 20213406
May 2021402
Jun 2021004
Jul 2021005
Aug 2021005
Sep 2021009
Oct 202130026
Nov 202124017
Dec 20211806
Jan 20223001
Feb 20221604
Mar 20223604
Apr 202260010
May 20222809
Jun 20223604
Jul 20221601
Aug 20222805
Sep 20223206
Oct 20222406
Nov 20223204
Dec 20224005
Jan 20233405
Feb 20231802
Mar 20233001
Apr 20233006
May 20231801
Jun 2023802
Jul 2023805
Aug 20231803
Sep 2023604
Oct 20231809
Nov 20233004
Dec 20232602
Jan 20242003
Feb 20242202
Mar 202414034
Apr 20242004
May 20242608
Jun 20243401
Jul 20241604
Aug 20242002
Sep 20241604
Oct 20242009
Nov 20241506
Dec 202420010
Jan 202524025
Feb 2025004
Mar 20250012
Apr 2025005
May 2025007
Jun 2025009
Total13000385